高薬理活性原薬(HPAPI)の世界市場予測(~2023年):種類、合成、メーカー、治療分野

◆英語タイトル:High Potency APIs /HPAPI Market by Type (Innovative, Generic), Synthesis (Synthetic, Biotech, moAB, Vaccines, Recombinant Proteins), Manufacturer (Captive and Merchant), Therapy (Oncology, Glaucoma, Hormonal Imbalance) - Global Forecasts to 2023
◆商品コード:MAM-PH-4897
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2018年4月18日
◆ページ数:218
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

MarketsandMarketsが発行した当調査レポートでは、高薬理活性原薬(HPAPI)の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、合成別分析、メーカー別分析、治療分野別分析、高薬理活性原薬(HPAPI)の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

The global HPAPI market is expected to reach USD 26.84 Billion by 2023 from USD 17.72 Billion in 2018, at a CAGR 8.7%. The growth in this market is driven by factors such as increasing demand for oncology drugs, growing demand for antibody-drug conjugates, increasing focus of leading pharmaceutical companies on HPAPIs, advancements in HPAPI manufacturing technologies, and growing focus on precision medicine.
This report segments the HPAPIs market into type, type of manufacturer, type of synthesis, therapeutic application, and region. Based on type, the HPAPI market is segmented into innovative and generic APIs. In 2018, the innovative HPAPIs segment is expected to account for the largest share of the market. The large share can be attributed to the increased investments of innovator companies in R&D, manufacture, marketing, and supply of innovative HPAPIs as the revenue generated from these molecules are considerably high.

On the basis of type of manufacturer, the HPAPI market is segmented into captive HPAPI and merchant HPAPI manufacturers. In 2018, the captive HPAPI manufacturers segment is expected to account for the largest share of the market. The large share of this segment is attributed to the preference of innovative companies to maintain in-house manufacturing facilities for economic benefits.

On the basis of type of synthesis, the HPAPI market is categorized into synthetic and biotech HPAPIs. The synthetic HPAPI segment is expected to command the largest share in 2018. The increasing emergence of new molecules in the market, rising number of product approvals, technological advancements in synthesis, and ease of production are driving the growth of the synthetic HPAPI segment.

On the basis of therapeutic application, the market is segmented into oncology, hormonal imbalance, glaucoma, and other therapeutic applications. The oncology segment is expected to account for the largest share of the global HPAPI market in 2018. The growing incidence and prevalence of cancer across the globe and the launch of new target therapies in addition to technological advancements in the oncology HPAPI-antibody conjugate technology are major factors contributing to the growth of this segment.

High Potency API /HPAPI Market

Geographically, the HPAPIs market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to dominate the market in 2018, followed by Europe. However, Asia is expected to grow at the highest CAGR during the forecast period. Factors such as growth in geriatric population, high prevalence of chronic and lifestyle diseases, increase in disposable income, prevalence of lifestyle- and age-related diseases, government efforts to reform healthcare and encourage the adoption of generics, and growing market for merchant manufacturers in this region owing to the low labor and manufacturing costs are driving the growth of the HPAPIs market in Asia.

While the HPAPI market presents significant growth opportunities, market growth may be hindered factors like requirement of large investments, discrepancies in HPAPI banding systems, uncertainties associated with products and high risk of cross-contamination are the major factors.

The HPAPIs market is competitive in nature, with several major players competing for market space. Some of the prominent players in this market are Pfizer Inc. (US), Novartis International AG (Switzerland), Merck & Co. (US), Teva Pharmaceutical Industries Ltd. (Israel), Mylan, Inc. (US), Boehringer Ingelheim (Germany), Sanofi (France), AbbVie (US), Eli Lilly and Company (US), AstraZeneca plc (UK), Bristol-Myers Squibb (US), and GlaxoSmithKline plc (UK).

【レポートの目次】

1 HPAPI Market: Introduction (Page No. – 21)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Market Stakeholders

2 HPAPI Market: Research Methodology (Page No. – 24)
2.1 Secondary Data
2.1.1 Key Data From Secondary Sources
2.2 Primary Data
2.2.1 Key Data From Primaries
2.2.2 Insights From Industry Experts
2.3 Market Size Estimation
2.4 Market Breakdown and Data Triangulation
2.5 Assumptions for the Study

3 HPAPI Market: Executive Summary (Page No. – 32)

4 HPAPI Market: Premium Insights (Page No. – 37)
4.1 High-Potency Active Pharmaceutical Ingredients Market: Overview
4.2 Global Market, By Type, 2018 vs 2023 (USD Billion)
4.3 Global Market, By Type of Synthesis, 2018 vs 2023 (USD Billion)
4.4 Global Market, By Therapeutic Area (2018–2023)
4.5 Geographical Snapshot of the Global Market

5 HPAPI Market: Overview (Page No. – 41)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Demand for Oncology Drugs
5.2.1.2 Growing Demand for Antibody-Drug Conjugates
5.2.1.3 Increasing Focus of Leading Pharmaceutical Companies on HPAPI
5.2.1.4 Advancements in HPAPI Manufacturing Technologies
5.2.1.5 Growing Focus on Precision Medicine
5.2.2 Restraints
5.2.2.1 Requirement of Large Investments
5.2.2.2 Discrepancies in HPAPI Banding Systems
5.2.2.3 Uncertainties Associated With Products
5.2.2.4 High Risk of Cross-Contamination
5.2.3 Opportunities
5.2.3.1 Growing Opportunities for CMOS and CDMOS
5.2.3.2 Emerging Markets
5.2.4 Challenges
5.2.4.1 Need for Appropriate Process Designs
5.2.4.2 Constant Evolution of Industry Standards and Technologies

6 High-Potency Active Pharmaceutical Ingredients Classification and Overview (Page No. – 49)
6.1 Introduction
6.2 High-Potency Active Pharmaceutical Ingredients Classification as Per Safebridge Consultants

7 HPAPI Market, By Type (Page No. – 52)
7.1 Introduction
7.2 Innovative High-Potency Active Pharmaceutical Ingredients
7.3 Generic High-Potency Active Pharmaceutical Ingredients

8 HPAPI Market, By Type of Synthesis (Page No. – 60)
8.1 Introduction
8.2 Synthetic High-Potency Active Pharmaceutical Ingredients
8.2.1 Synthetic High-Potency Active Pharmaceutical Ingredients Market, By Type
8.2.1.1 Innovative Synthetic HPAPI
8.2.1.2 Generic Synthetic HPAPI
8.3 Biotech High-Potency Active Pharmaceutical Ingredients
8.3.1 Biotech High-Potency Active Pharmaceutical Ingredients Market, By Type
8.3.1.1 Innovative Biotech HPAPI
8.3.1.2 Biosimilars
8.3.2 Biotech High-Potency Active Pharmaceutical Ingredients Market, By Product
8.3.2.1 Monoclonal Antibodies
8.3.2.2 Vaccines
8.3.2.3 Recombinant Proteins

9 HPAPI Market, By Type of Manufacturer (Page No. – 79)
9.1 Introduction
9.2 Captive HPAPI Manufacturers
9.3 Merchant HPAPI Manufacturers
9.3.1 Merchant HPAPI Manufacturers Market, By Type
9.3.1.1 Innovative Merchant HPAPI Manufacturers
9.3.1.2 Generic Merchant HPAPI Manufacturers
9.3.2 Merchant HPAPI Manufacturers Market, By Type of Synthesis
9.3.2.1 Synthetic HPAPIs
9.3.2.2 Biotech HPAPIs

10 HPAPI Market, By Therapeutic Application (Page No. – 97)
10.1 Introduction
10.2 Oncology
10.3 Hormonal Imbalance
10.4 Glaucoma
10.5 Other Therapeutic Applications

11 HPAPI Market, By Region (Page No. – 108)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 UK
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest of Europe (RoE)
11.4 Asia
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of Asia (RoA)
11.5 Rest of the World (RoW)

12 Competitive Landscape (Page No. – 177)
12.1 Overview
12.2 Market Ranking Analysis
12.3 Competitive Situation and Trends
12.3.1 Agreements, Collaborations, and Partnerships
12.3.2 Mergers and Acquisitions
12.3.3 Expansions

13 Company Profiles (Page No. – 183)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 Pfizer
13.2 Novartis International AG
13.3 Sanofi
13.4 F. Hoffmann-La Roche
13.5 Bristol-Myers Squibb
13.6 Boehringer Ingelheim
13.7 Teva Pharmaceutical Industries
13.8 ELI Lilly and Company
13.9 Merck
13.10 Abbvie
13.11 Mylan
13.12 Bayer

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. – 208)
14.1 Insights From Industry Experts
14.2 Discussion Guide
14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
14.4 Introducing RT: Real-Time Market Intelligence
14.5 Available Customizations
14.6 Related Reports
14.7 Author Details

List of Tables (239 Tables)

Table 1 Pipeline of Oncology Drugs (2018)
Table 2 Therapeutic Monoclonal Antibodies Approved By the Fda in 2016
Table 3 HPAPI Market, By Type, 2016–2023 (USD Million)
Table 4 Innovative HPAPI Market, By Region, 2016–2023 (USD Million)
Table 5 North America: Innovative HPAPI Market, By Country, 2016–2023 (USD Million)
Table 6 Europe: Innovative HPAPI Market, By Country, 2016–2023 (USD Million)
Table 7 Asia: Innovative HPAPI Market, By Country, 2016–2023 (USD Million)
Table 8 Generic High-Potency Active Pharmaceutical Ingredients Market, By Region, 2016–2023 (USD Million)
Table 9 North America: Generic High-Potency Active Pharmaceutical Ingredients Market, By Country, 2016–2023 (USD Million)
Table 10 Europe: Generic HPAPI Market, By Country, 2016–2023 (USD Million)
Table 11 Asia: Generic HPAPI Market, By Country, 2016–2023 (USD Million)
Table 12 HPAPI Market, By Type of Synthesis, 2016- 2023 (USD Million)
Table 13 Synthetic HPAPI Market, By Region, 2016- 2023 (USD Million)
Table 14 North America: Synthetic HPAPI Market, By Country, 2016- 2023 (USD Million)
Table 15 Europe: Synthetic High-Potency Active Pharmaceutical Ingredients Market, By Country, 2016- 2023 (USD Million)
Table 16 Asia: Synthetic High-Potency Active Pharmaceutical Ingredients Market, By Country, 2016- 2023 (USD Million)
Table 17 Synthetic HPAPI Market, By Type, 2015-2022 (USD Million)
Table 18 Innovative Synthetic HPAPI Market, By Region, 2016- 2023 (USD Million)
Table 19 North America: Innovative Synthetic HPAPI Market, By Country, 2016- 2023 (USD Million)
Table 20 Europe: Innovative Synthetic HPAPI Market, By Country, 2016- 2023 (USD Million)
Table 21 Asia: Innovative Synthetic HPAPI Market, By Country, 2016- 2023 (USD Million)
Table 22 Generic Synthetic High-Potency Active Pharmaceutical Ingredients Market, By Region, 2016- 2023 (USD Million)
Table 23 North America: Generic Synthetic HPAPI Market, By Country, 2016- 2023 (USD Million)
Table 24 Europe: Generic Synthetic HPAPI Market, By Country, 2016- 2023 (USD Million)
Table 25 Asia: Generic Synthetic HPAPI Market, By Country, 2016- 2023 (USD Million)
Table 26 Biotech HPAPI Market, By Region, 2016- 2023 (USD Million)
Table 27 North America: Biotech HPAPI Market, By Country, 2016- 2023 (USD Million)
Table 28 Europe: Biotech HPAPI Market, By Country, 2016- 2023 (USD Million)
Table 29 Asia: Biotech HPAPI Market, By Country, 2016- 2023 (USD Million)
Table 30 Biotech HPAPI Market, By Type, 2016- 2023 (USD Million)
Table 31 Innovative Biotech High-Potency Active Pharmaceutical Ingredients Market, By Region, 2016- 2023 (USD Million)
Table 32 North America: Innovative Biotech HPAPI Market, By Country, 2016- 2023 (USD Million)
Table 33 Europe: Innovative Biotech HPAPI Market, By Country, 2016- 2023 (USD Million)
Table 34 Asia: Innovative Biotech HPAPI Market, By Country, 2016- 2023 (USD Million)
Table 35 Biosimilars Market, By Region, 2016- 2023 (USD Million)
Table 36 North America: Biosimilars Market, By Country, 2016- 2023 (USD Million)
Table 37 Europe: Biosimilars Market, By Country, 2016- 2023 (USD Million)
Table 38 Asia: Biosimilars Ingredients Market, By Country, 2016- 2023 (USD Million)
Table 39 Biotech High-Potency Active Pharmaceutical Ingredients Market, By Product, 2016- 2023 (USD Million)
Table 40 Monoclonal Antibodies Market, By Region, 2016- 2023 (USD Million)
Table 41 Vaccines Market, By Region, 2016- 2023 (USD Million)
Table 42 Recombinant Proteins Market, By Region, 2016- 2023 (USD Million)
Table 43 HPAPI Market, By Type of Manufacturer, 2016–2023 (USD Million)
Table 44 Captive HPAPI Manufacturers Market, By Region, 2016–2023 (USD Million)
Table 45 North America: Captive HPAPI Manufacturers Market, By Country, 2016–2023 (USD Million)
Table 46 Europe: Captive HPAPI Manufacturers Market, By Country, 2016–2023 (USD Million)
Table 47 Asia: Captive HPAPI Manufacturers Market, By Country, 2016–2023 (USD Million)
Table 48 Merchant HPAPI Manufacturers Market, By Region, 2016–2023 (USD Million)
Table 49 North America: Merchant HPAPI Manufacturers Market, By Country, 2016–2023 (USD Million)
Table 50 Europe: Merchant HPAPI Manufacturers Market, By Country, 2016–2023 (USD Million)
Table 51 Asia: Merchant HPAPI Manufacturers Market, By Country, 2016–2023 (USD Million)
Table 52 Global Merchant HPAPI Manufacturers Market, By Type, 2016-2023, (USD Million)
Table 53 Innovative Merchant HPAPI Manufacturers Market, By Region, 2016–2023 (USD Million)
Table 54 North America: Innovative Merchant HPAPI Manufacturers Market, By Country, 2016–2023 (USD Million)
Table 55 Europe: Innovative Merchant HPAPI Manufacturers Market, By Country, 2016–2023 (USD Million)
Table 56 Asia: Innovative Merchant HPAPI Manufacturers Market, By Country, 2016–2023 (USD Million)
Table 57 Generic Merchant HPAPI Manufacturers Market, By Region, 2016–2023 (USD Million)
Table 58 North America: Generic Merchant HPAPI Manufacturers Market, By Country, 2016–2023 (USD Million)
Table 59 Europe: Generic Merchant HPAPI Manufacturers Market, By Country, 2016–2023 (USD Million)
Table 60 Asia: Generic Merchant HPAPI Manufacturers Market, By Country, 2016–2023 (USD Million)
Table 61 Merchant HPAPI Manufacturers Market, By Type of Synthesis, 2016-2023, (USD Million)
Table 62 Merchant Synthetic HPAPI Manufacturers Market, By Region, 2016–2023 (USD Million)
Table 63 North America: Merchant Synthetic HPAPI Manufacturers Market, By Country, 2016–2023 (USD Million)
Table 64 Europe: Merchant Synthetic HPAPI Manufacturers Market, By Country, 2016–2023 (USD Million)
Table 65 Asia: Merchant Synthetic HPAPI Manufacturers Market, By Country, 2016–2023 (USD Million)
Table 66 Merchant Biotech HPAPI Manufacturers Market, By Region, 2016–2023 (USD Million)
Table 67 North America: Merchant Biotech HPAPI Manufacturers Market, By Country, 2016–2023 (USD Million)
Table 68 Europe: Merchant Biotech HPAPI Manufacturers Market, By Country, 2016–2023 (USD Million)
Table 69 Asia: Merchant Biotech HPAPI Manufacturers Market, By Country, 2016–2023 (USD Million)
Table 70 Global Market, By Therapeutic Application, 2016–2023 (USD Million)
Table 71 High-Potency Active Pharmaceutical Ingredients Market for Oncology, By Region, 2016–2023 (USD Million)
Table 72 North America: Market for Oncology, By Country, 2016–2023 (USD Million)
Table 73 Europe: Market for Oncology, By Country, 2016–2023 (USD Million)
Table 74 Asia: Market for Oncology, By Country, 2016–2023 (USD Million)
Table 75 HPAPI Market for Hormonal Imbalance, By Region, 2016–2023 (USD Million)
Table 76 North America: Market for Hormonal Imbalance, By Country, 2016–2023 (USD Million)
Table 77 Europe: Market for Hormonal Imbalance, By Country, 2016–2023 (USD Million)
Table 78 Asia: Market for Hormonal Imbalance, By Country, 2016–2023 (USD Million)
Table 79 High-Potency Active Pharmaceutical Ingredients Market for Glaucoma, By Region, 2016–2023 (USD Million)
Table 80 North America: Market for Glaucoma, By Country, 2016–2023 (USD Million)
Table 81 Europe: Market for Glaucoma, By Country, 2016–2023 (USD Million)
Table 82 Asia: Market for Glaucoma, By Country, 2016–2023 (USD Million)
Table 83 HPAPI Market for Other Therapeutic Applications, By Region, 2016–2023 (USD Million)
Table 84 North America: HPAPI Market for Other Therapeutic Applications, By Country, 2016–2023 (USD Million)
Table 85 Europe: HPAPI Market for Other Therapeutic Applications, By Country, 2016–2023 (USD Million)
Table 86 Asia: HPAPI Market for Other Therapeutic Applications, By Country, 2016–2023 (USD Million)
Table 87 HPAPI Market, By Region, 2016–2023 (USD Million)
Table 88 North America: HPAPI Market, By Country, 2016–2023 (USD Million)
Table 89 North America: HPAPI Market, By Type, 2016–2023 (USD Million)
Table 90 North America: HPAPI Market, By Type of Manufacturer, 2016–2023 (USD Million)
Table 91 North America: Merchant HPAPI Manufacturers Market, By Type, 2016–2023 (USD Million)
Table 92 North America: Merchant HPAPI Manufacturers Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 93 North America: High-Potency Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 94 North America: Synthetic HPAPI Market, By Type, 2016–2023 (USD Million)
Table 95 North America: Biotech HPAPI Market, By Type, 2016–2023 (USD Million)
Table 96 North America: Biotech HPAPI Market, By Product, 2016–2023 (USD Million)
Table 97 North America: HPAPI Market, By Therapeutic Application, 2016–2023 (USD Million)
Table 98 US: High-Potency Active Pharmaceutical Ingredients Market, By Type, 2016–2023 (USD Million)
Table 99 US: HPAPI Market, By Type of Manufacturer, 2016–2023 (USD Million)
Table 100 US: Merchant HPAPI Manufacturers Market, By Type, 2016–2023 (USD Million)
Table 101 US: Merchant HPAPI Manufacturers Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 102 US: High-Potency API Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 103 US: Synthetic High-Potency API Market, By Type, 2016–2023 (USD Million)
Table 104 US: Biotech High-Potency API Market, By Type, 2016–2023 (USD Million
Table 105 US: Biotech High-Potency API Market, By Product, 2016–2023 (USD Million)
Table 106 US: High-Potency API Market, By Therapeutic Application, 2016–2023 (USD Million)
Table 107 Canada: HPAPI Market, By Type, 2016–2023 (USD Million)
Table 108 Canada: HPAPI Market, By Type of Manufacturer, 2016–2023 (USD Million)
Table 109 Canada: Merchant HPAPI Manufacturers Market, By Type, 2016–2023 (USD Million)
Table 110 Canada: Merchant HPAPI Manufacturers Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 111 Canada: High-Potency API Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 112 Canada: Synthetic High-Potency API Market, By Type, 2016–2023 (USD Million)
Table 113 Canada: Biotech High-Potency API Market, By Type, 2016–2023 (USD Million)
Table 114 Canada: Biotech High-Potency API Market, By Product, 2016–2023 (USD Million)
Table 115 Canada: High-Potency API Market, By Therapeutic Application, 2016–2023 (USD Million)
Table 116 Europe: High-Potency Active Pharmaceutical Ingredients Market, By Country, 2016–2023 (USD Million)
Table 117 Europe: Market, By Type, 2016–2023 (USD Million)
Table 118 Europe: Market, By Type of Manufacturer, 2016–2023 (USD Million)
Table 119 Europe: Merchant HPAPI Manufacturers Market, By Type, 2016–2023 (USD Million)
Table 120 Europe: Merchant HPAPI Manufacturers Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 121 Europe: Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 122 Europe: Synthetic High-Potency Active Pharmaceutical Ingredients Market, By Type, 2016–2023 (USD Million)
Table 123 Europe: Biotech HPAPI Market, By Type, 2016–2023 (USD Million)
Table 124 Europe: Biotech HPAPI Market, By Product, 2016–2023 (USD Million)
Table 125 Europe: High-Potency Active Pharmaceutical Ingredients Market, By Therapeutic Application, 2016–2023 (USD Million)
Table 126 Germany: HPAPI Market, By Type, 2016–2023 (USD Million)
Table 127 Germany: HPAPI Market, By Type of Manufacturer, 2016–2023 (USD Million)
Table 128 Germany: Merchant HPAPI Manufacturers Market, By Type, 2016–2023 (USD Million)
Table 129 Germany: Merchant HPAPI Manufacturers Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 130 Germany: HPAPI Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 131 Germany: Synthetic High-Potency Active Pharmaceutical Ingredients Market, By Type, 2016–2023 (USD Million)
Table 132 Germany: Biotech HPAPI Market, By Type, 2016–2023 (USD Million)
Table 133 Germany: Biotech HPAPI Market, By Product, 2016–2023 (USD Million)
Table 134 Germany: High-Potency Active Pharmaceutical Ingredients Market, By Therapeutic Application, 2016–2023 (USD Million)
Table 135 France: HPAPI Market, By Type, 2016–2023 (USD Million)
Table 136 France: HPAPI Market, By Type of Manufacturer, 2016–2023 (USD Million)
Table 137 France: Merchant HPAPI Manufacturers Market, By Type, 2016–2023 (USD Million)
Table 138 France: Merchant HPAPI Manufacturers Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 139 France: HPAPI Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 140 France: Synthetic High-Potency Active Pharmaceutical Ingredients Market, By Type, 2016–2023 (USD Million)
Table 141 France: Biotech HPAPI Market, By Type, 2016–2023 (USD Million)
Table 142 France: Biotech HPAPI Market, By Product, 2016–2023 (USD Million)
Table 143 France: High-Potency Active Pharmaceutical Ingredients Market, By Therapeutic Application, 2016–2023 (USD Million)
Table 144 UK: HPAPI Market, By Type, 2016–2023 (USD Million)
Table 145 UK: HPAPI Market, By Type of Manufacturer, 2016–2023 (USD Million)
Table 146 UK: Merchant HPAPI Manufacturers Market, By Type, 2016–2023 (USD Million)
Table 147 UK: Merchant HPAPI Manufacturers Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 148 UK: HPAPI Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 149 UK: Synthetic High-Potency Active Pharmaceutical Ingredients Market, By Type, 2016–2023 (USD Million)
Table 150 UK: Biotech HPAPI Market, By Type, 2016–2023 (USD Million)
Table 151 UK: Biotech High-Potency Active Pharmaceutical Ingredients Market, By Product, 2016–2023 (USD Million)
Table 152 UK: HPAPI Market, By Therapeutic Application, 2016–2023 (USD Million)
Table 153 Italy: HPAPI Market, By Type, 2016–2023 (USD Million)
Table 154 Italy: HPAPI Market, By Type of Manufacturer, 2016–2023 (USD Million)
Table 155 Italy: Merchant HPAPI Manufacturers Market, By Type, 2016–2023 (USD Million)
Table 156 Italy: Merchant HPAPI Manufacturers Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 157 Italy: High-Potency Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 158 Italy: Synthetic HPAPI Market, By Type, 2016–2023 (USD Million)
Table 159 Italy: Biotech High-Potency Active Pharmaceutical Ingredients Market, By Type, 2016–2023 (USD Million)
Table 160 Italy: Biotech HPAPI Market, By Product, 2016–2023 (USD Million)
Table 161 Italy: High-Potency Active Pharmaceutical Ingredients Market, By Therapeutic Application, 2016–2023 (USD Million)
Table 162 Spain: High-Potency API Market, By Type, 2016–2023 (USD Million)
Table 163 Spain: High-Potency API Market, By Type of Manufacturer, 2016–2023 (USD Million)
Table 164 Spain: Merchant HPAPI Manufacturers Market, By Type, 2016–2023 (USD Million)
Table 165 Spain: Merchant Manufacturers Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 166 Spain: High-Potency API Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 167 Spain: Synthetic High-Potency Active Pharmaceutical Ingredients Market, By Type, 2016–2023 (USD Million)
Table 168 Spain: Biotech HPAPI Market, By Type, 2016–2023 (USD Million)
Table 169 Spain: Biotech High-Potency Active Pharmaceutical Ingredients Market, By Product, 2016–2023 (USD Million)
Table 170 Spain: High-Potency API Market, By Therapeutic Application, 2016–2023 (USD Million)
Table 171 RoE: High-Potency Active Pharmaceutical Ingredients Market, By Type, 2016–2023 (USD Million)
Table 172 RoE: High-Potency API Market, By Type of Manufacturer, 2016–2023 (USD Million)
Table 173 RoE: Merchant HPAPI Manufacturers Market, By Type, 2016–2023 (USD Million)
Table 174 RoE: Merchant Manufacturers Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 175 RoE: High-Potency Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 176 RoE: Synthetic High-Potency API Market, By Type, 2016–2023 (USD Million)
Table 177 RoE: Biotech High-Potency Active Pharmaceutical Ingredients Market, By Type, 2016–2023 (USD Million)
Table 178 RoE: Biotech HPAPI Market, By Product, 2016–2023 (USD Million)
Table 179 RoE: High-Potency API Market, By Therapeutic Application, 2016–2023 (USD Million)
Table 180 Asia: High-Potency Active Pharmaceutical Ingredients Market, By Country, 2016–2023 (USD Million)
Table 181 Asia: HPAPI Market, By Type, 2016–2023 (USD Million)
Table 182 Asia: HPAPI Market, By Type of Manufacturer, 2016–2023 (USD Million)
Table 183 Asia: Merchant HPAPI Manufacturers Market, By Type, 2016–2023 (USD Million)
Table 184 Asia: Merchant HPAPI Manufacturers Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 185 Asia: High-Potency Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 186 Asia: Synthetic High-Potency Active Pharmaceutical Ingredients Market, By Type, 2016–2023 (USD Million)
Table 187 Asia: Biotech HPAPI Market, By Type, 2016–2023 (USD Million)
Table 188 Asia: Biotech High-Potency Active Pharmaceutical Ingredients Market, By Product, 2016–2023 (USD Million)
Table 189 Asia: HPAPI Market, By Therapeutic Application, 2016–2023 (USD Million)
Table 190 Japan: High-Potency Active Pharmaceutical Ingredients Market, By Type, 2016–2023 (USD Million)
Table 191 Japan: HPAPI Market, By Type of Manufacturer, 2016–2023 (USD Million)
Table 192 Japan: Merchant HPAPI Manufacturers Market, By Type, 2016–2023 (USD Million)
Table 193 Japan: Merchant HPAPI Manufacturers Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 194 Japan: HPAPI Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 195 Japan: Synthetic High-Potency Active Pharmaceutical Ingredients Market, By Type, 2016–2023 (USD Million)
Table 196 Japan: Biotech HPAPI Market, By Type, 2016–2023 (USD Million)
Table 197 Japan: Biotech HPAPI Market, By Product, 2016–2023 (USD Million)
Table 198 Japan: HPAPI Market, By Therapeutic Application, 2016–2023 (USD Million)
Table 199 China: HPAPI Market, By Type, 2016–2023 (USD Million)
Table 200 China: High-Potency Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2016–2023 (USD Million)
Table 201 China: Merchant HPAPI Manufacturers Market, By Type, 2016–2023 (USD Million)
Table 202 China: Merchant HPAPI Manufacturers Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 203 China: HPAPI Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 204 China: Synthetic High-Potency Active Pharmaceutical Ingredients Market, By Type, 2016–2023 (USD Million)
Table 205 China: Biotech HPAPI Market, By Type, 2016–2023 (USD Million)
Table 206 China: Biotech HPAPI Market, By Product, 2016–2023 (USD Million)
Table 207 China: HPAPI Market, By Therapeutic Application, 2016–2023 (USD Million)
Table 208 India: High-Potency Active Pharmaceutical Ingredients Market, By Type, 2016–2023 (USD Million)
Table 209 India: HPAPI Market, By Type of Manufacturer, 2016–2023 (USD Million)
Table 210 India: Merchant HPAPI Manufacturers Market, By Type, 2016–2023 (USD Million)
Table 211 India: Merchant HPAPI Manufacturers Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 212 India: HPAPI Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 213 India: Synthetic High-Potency Active Pharmaceutical Ingredients Market, By Type, 2016–2023 (USD Million)
Table 214 India: Biotech HPAPI Market, By Type, 2016–2023 (USD Million)
Table 215 India: Biotech HPAPI Market, By Product, 2016–2023 (USD Million)
Table 216 India: HPAPI Market, By Therapeutic Application, 2016–2023 (USD Million)
Table 217 RoA: High-Potency Active Pharmaceutical Ingredients Market, By Type, 2016–2023 (USD Million)
Table 218 RoA: HPAPI Market, By Type of Manufacturer, 2016–2023 (USD Million)
Table 219 RoA: Merchant HPAPI Manufacturers Market, By Type, 2016–2023 (USD Million)
Table 220 RoA: Merchant HPAPI Manufacturers Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 221 RoA: HPAPI Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 222 RoA: Synthetic High-Potency Active Pharmaceutical Ingredients Market, By Type, 2016–2023 (USD Million)
Table 223 RoA: Biotech HPAPI Market, By Type, 2016–2023 (USD Million)
Table 224 RoA: Biotech HPAPI Market, By Product, 2016–2023 (USD Million)
Table 225 RoA: High-Potency Active Pharmaceutical Ingredients Market, By Therapeutic Application, 2016–2023 (USD Million)
Table 226 RoW: HPAPI Market, By Type, 2016–2023 (USD Million)
Table 227 RoW: HPAPI Market, By Type of Manufacturer, 2016–2023 (USD Million)
Table 228 RoW: Merchant HPAPI Manufacturers Market, By Type, 2016–2023 (USD Million)
Table 229 RoW: Merchant HPAPI Manufacturers Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 230 RoW: High-Potency Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2016–2023 (USD Million)
Table 231 RoW: Synthetic HPAPI Market, By Type, 2016–2023 (USD Million)
Table 232 RoW: Biotech HPAPI Market, By Type, 2016–2023 (USD Million)
Table 233 RoW: Biotech HPAPI Market, By Product, 2016–2023 (USD Million)
Table 234 RoW: High-Potency Active Pharmaceutical Ingredients Market, By Therapeutic Application, 2016–2023 (USD Million)
Table 235 Market Ranking Analysis, By Key Player, 2017
Table 236 Agreements, Collaborations, Partnerships, and Alliances (2015–2018)
Table 237 Mergers and Acquisitions (2015-2018)
Table 238 Expansions (2015–2018)
Table 239 Exchange Rates (Utilized for the Conversion of Chf to USD)

List of Figures (42 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation: Bottom-Up Approach
Figure 4 Market Size Estimation: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 High-Potency Active Pharmaceutical Ingredients Market, By Type, 2018 vs 2023
Figure 7 HPAPI Market, By Type of Manufacturer, 2018 vs 2023
Figure 8 HPAPI Market, By Type of Synthesis, 2018 vs 2023
Figure 9 HPAPI Market, By Therapeutic Application, 2018 vs 2023
Figure 10 Geographic Snapshot of the High-Potency Active Pharmaceutical Ingredients Market (2018–2023)
Figure 11 Increasing Demand for Oncology Drugs & Antibody-Drug Conjugates—Major Factor Driving Market Growth During the Forecast Period
Figure 12 Innovative HPAPIs Will Continue to Dominate the Global Market in 2023
Figure 13 Synthetic HPAPIs to Account for the Largest Market Share in 2018
Figure 14 Oncology Segment to Register the Highest CAGR During the Forecast Period
Figure 15 China & India to Register High Growth Rates During 2018–2023
Figure 16 High-Potency Active Pharmaceutical Ingredients Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 HPAPI Market, By Type
Figure 18 Innovative HPAPIs Segment to Dominate the High-Potency Active Pharmaceutical Ingredients Market in 2018
Figure 19 Synthetic Segment to Dominate the Market in 2018
Figure 20 Captive HPAPI Manufacturers Segment is Expected to Account for Largest Share of the Market in 2018
Figure 21 North America to Dominate the Captive HPAPI Manufacturers Market in 2018
Figure 22 Oncology Segment to Dominate the High-Potency Active Pharmaceutical Ingredients Market, By Therapeutic Application (2018)
Figure 23 Asia to Witness the Highest Growth Rate During the Forecast Period (2018–2023)
Figure 24 North America: HPAPI Market Snapshot (2018)
Figure 25 Europe: HPAPI Market Snapshot
Figure 26 Asia: HPAPI Market Snapshot
Figure 27 Rest of the World: HPAPI Market Snapshot
Figure 28 Key Developments in the HPAPI Market, 2015–2018
Figure 29 Market Evolution Framework— Agreements, Collaborations, Partnerships, and Alliances Fueled Market Growth
Figure 30 Battle for Market Share: Agreements, Collaborations, and Partnerships Was the Key Strategy Adopted By Market Players (2015–2018)
Figure 31 Pfizer: Company Snapshot (2016)
Figure 32 Novartis International AG: Company Snapshot (2016)
Figure 33 Sanofi: Company Snapshot (2017)
Figure 34 F. Hoffmann-La Roche: Company Snapshot (2017)
Figure 35 Bristol-Myers Squibb: Company Snapshot (2016)
Figure 36 Boehringer Ingelheim: Company Snapshot (2016)
Figure 37 Teva Pharmaceutical Industries: Company Snapshot (2017)
Figure 38 ELI Lilly and Company: Company Snapshot (2016)
Figure 39 Merck: Company Snapshot (2016)
Figure 40 Abbvie: Company Snapshot (2017)
Figure 41 Mylan: Company Snapshot (2017)
Figure 42 Bayer: Company Snapshot (2017)



【レポートのキーワード】

高薬理活性原薬(HPAPI)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[高薬理活性原薬(HPAPI)の世界市場予測(~2023年):種類、合成、メーカー、治療分野]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆